The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Very Low Density Lipoprotein Receptor, a Negative Regulator of the wnt Signaling Pathway and Choroidal Neovascularization
Abstract
Choroidal neovascularization (CNV) in age-related macular degeneration is a leading cause of blindness. Very low density lipoprotein receptor gene knock-out (Vldlr(-/-)) mice have been shown to develop subretinal neovascularization (NV) with an unknown mechanism. The present study showed that in Vldlr(-/-) mice, NV initiated in the choroid and progressed to penetrate the retinal pigment epithelium layer, proliferating in the subretinal space. This phenotype recapitulated what is seen in wet age-related macular degeneration, suggesting that this is a CNV model. The CNV correlated with overexpression of vascular endothelial growth factor in Vldlr(-/-) eyecups and was blocked by a neutralizing antibody against vascular endothelial growth factor receptor-2. The wnt co-receptor LRP5/6 expression was significantly up-regulated in Vldlr(-/-) eyecups compared with that in wild-type mice. Significantly, Vldlr(-/-) mice showed impaired phosphorylation of downstream effectors of the wnt signaling pathway, glycogen synthase kinase-3beta (GSK-3beta), and beta-catenin, concomitant with increased levels of free GSK-3beta and beta-catenin, suggesting an increased activity of the wnt pathway. Down-regulation of VLDLR by small interference RNA resulted in up-regulation of LRP5/6 expression and activation of beta-catenin in cultured endothelial cells. Furthermore, Dickkopf-1, a specific inhibitor of the wnt pathway, effectively decreased vascular endothelial growth factor and beta-catenin level…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The VLDLR ectodomain is an endogenous inhibitor of canonical Wnt signaling through binding with LRP6.
“Recently, our group identified the VLDLR ectodomain as an endogenous inhibitor of canonical Wnt signaling through binding with the Wnt coreceptor, low-density lipoprotein receptor–related protein 6 (LRP6) (6, 7).”
From ADAM17 mediates ectodomain shedding of the soluble VLDL receptor fragment in the retinal epithelium (2021) · cites this paper as [6]
Vldlr gene knockout results in Wnt signaling overactivation and subsequently pathological angiogenesis and inflammation.
“In addition, Vldlr gene KO results in Wnt signaling overactivation and subsequently pathological angiogenesis and inflammation (6, 8).”
From ADAM17 mediates ectodomain shedding of the soluble VLDL receptor fragment in the retinal epithelium (2021) · cites this paper as [6]
Citations
Cites
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
RPE65 Gene Delivery Restores Isomerohydrolase Activity and Prevents Early Cone Loss in Rpe65−/−Mice
Chen, Y., Moiseyev, G., Takahashi, Y., & Ma, J.-X. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0965 · Cited by 80
Self-citation
Flagged first, then by citations
Research works printed but not linked: 50
- Anonyms, 2004, Morb. Mortal Wkly. Rep., 53, 1069
- Cursiefen, 1997, Klin. Monatsbl. Augenheilkd., 210, 341, 10.1055/s-2008-1035072 · DOI
- Nozaki, 2006, Proc. Natl. Acad. Sci. U. S. A., 103, 2328, 10.1073/pnas.0408835103 · DOI · Paper page
- Connolly, 1988, Microvasc. Res., 36, 275, 10.1016/0026-2862(88)90028-3 · DOI
- Kapustina, 1960, Arch. Anat. Histol. Embryol., 39, 16
- Cogan, 1963, Trans. Ophthalmol. Soc. UK, 83, 465
- Fruttiger, 2002, Investig. Ophthalmol. Vis. Sci., 43, 522
- Miller, 1997, Am. J. Pathol., 151, 13
- Leung, 1989, Science, 246, 1306, 10.1126/science.2479986 · DOI
- Tamai, 2004, Mol. Cell, 13, 149, 10.1016/S1097-2765(03)00484-2 · DOI · Paper page
- Dale, 1998, Biochem. J., 329, 209, 10.1042/bj3290209 · DOI
- Orsulic, 1996, Curr. Biol., 6, 1363, 10.1016/S0960-9822(96)00731-2 · DOI
- Ojesina, 2004, J. Pediatr. Surg., 39, 1446, 10.1016/j.jpedsurg.2004.06.003 · DOI
- Tachikawa, 2004, Proc. Natl. Acad. Sci. U. S. A., 101, 15225, 10.1073/pnas.0406473101 · DOI
- Easwaran, 2003, Cancer Res., 63, 3145
- Goodwin, 2002, Angiogenesis, 5, 1, 10.1023/A:1021563510866 · DOI
- Masckauchan, 2006, Physiology (Bethesda), 21, 181
- Robitaille, 2002, Nat. Genet., 32, 326, 10.1038/ng957 · DOI
- Kondo, 2003, Br. J. Ophthalmol., 87, 1291, 10.1136/bjo.87.10.1291 · DOI
- Kaykas, 2004, Nat. Cell Biol., 6, 52, 10.1038/ncb1081 · DOI
- Toomes, 2004, Am. J. Hum. Genet., 74, 721, 10.1086/383202 · DOI
- Xu, 2004, Cell, 116, 883, 10.1016/S0092-8674(04)00216-8 · DOI · Paper page
- Richter, 1998, Investig. Ophthalmol. Vis. Sci., 39, 2450
- Rehm, 2002, J. Neurosci., 22, 4286, 10.1523/JNEUROSCI.22-11-04286.2002 · DOI
- Kim, 2006, Arterioscler. Thromb. Vasc. Biol., 26, 91, 10.1161/01.ATV.0000193569.12490.4b · DOI
- Carmeliet, 1999, Cell, 98, 147, 10.1016/S0092-8674(00)81010-7 · DOI
- Frykman, 1995, Proc. Natl. Acad. Sci. U. S. A., 92, 8453, 10.1073/pnas.92.18.8453 · DOI · Paper page
- Tiebel, 1999, Atherosclerosis, 145, 239, 10.1016/S0021-9150(99)00068-4 · DOI
- Heckenlively, 2003, Retina, 23, 518, 10.1097/00006982-200308000-00012 · DOI
- Wu, 2004, Investig. Ophthalmol. Vis. Sci., 45, 3857, 10.1167/iovs.03-1302 · DOI
- Blaauwgeers, 1999, Am. J. Pathol., 155, 421, 10.1016/S0002-9440(10)65138-3 · DOI
- Masckauchan, 2006, Mol. Biol. Cell, 17, 5163, 10.1091/mbc.e06-04-0320 · DOI
- Zhang, 2001, Cancer Res., 61, 6050
- Orlandini, 2003, J. Biol. Chem., 278, 44650, 10.1074/jbc.M304255200 · DOI
- Wyne, 1996, Arterioscler. Thromb. Vasc. Biol., 16, 407, 10.1161/01.ATV.16.3.407 · DOI
- Spilsbury, 2000, Am. J. Pathol., 157, 135, 10.1016/S0002-9440(10)64525-7 · DOI
- Nagineni, 2003, J. Cell. Physiol., 197, 453, 10.1002/jcp.10378 · DOI
- Ida, 2003, Investig. Ophthalmol. Vis. Sci., 44, 5430, 10.1167/iovs.03-0609 · DOI
- Marneros, 2005, Am. J. Pathol., 167, 1451, 10.1016/S0002-9440(10)61231-X · DOI
- Takahashi, 1992, Proc. Natl. Acad. Sci. U. S. A., 89, 9252, 10.1073/pnas.89.19.9252 · DOI
- Sakai, 1994, J. Biol. Chem., 269, 2173, 10.1016/S0021-9258(17)42151-X · DOI
- Jokinen, 1994, J. Biol. Chem., 269, 26411, 10.1016/S0021-9258(18)47209-2 · DOI
- Battey, 1994, J. Biol. Chem., 269, 23268, 10.1016/S0021-9258(17)31648-4 · DOI · Paper page
- Glinka, 1998, Nature, 391, 357, 10.1038/34848 · DOI · Paper page
- Wang, 2000, Oncogene, 19, 1843, 10.1038/sj.onc.1203503 · DOI
- Takahashi, 2004, J. Atheroscler. Thromb., 11, 200, 10.5551/jat.11.200 · DOI
- Logan, 2004, Annu. Rev. Cell Dev. Biol., 20, 781, 10.1146/annurev.cellbio.20.010403.113126 · DOI · Paper page
- Hembrough, 2001, J. Biol. Chem., 276, 12241, 10.1074/jbc.M010395200 · DOI
- Nilsson, 1999, J. Lipid Res., 40, 913, 10.1016/S0022-2275(20)32126-X · DOI
- Haines, 2006, Investig. Ophthalmol. Vis. Sci., 47, 329, 10.1167/iovs.05-0116 · DOI · Paper page
Cited by
Sorted by citations
Animal models of age related macular degeneration
Pennesi, M. E., Neuringer, M., & Courtney, R. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.003 · Cited by 391
“Subretinal injection induced CNV. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 500 5.2.”
BackgroundInfluentialRetinopathy in Mice Induced by Disrupted All-trans-retinal Clearance
Maeda, A., Maeda, T., Golczak, M., & Palczewski, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804505200 · Cited by 300
A new perspective on lipid research in age-related macular degeneration
van Leeuwen, E. M., Emri, E., Merle, B. M. J., Colijn, J. M., Kersten, E., Cougnard-Gregoire, A., Dammeier, S., Meester-Smoor, M., Pool, F. M., de Jong, E. K., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.006 · Cited by 247
Dorrell, M. I., Aguilar, E., Jacobson, R., Yanes, O., Gariano, R., Heckenlively, J., Banin, E., Ramirez, G. A., Gasmi, M., Bird, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35977 · Cited by 127
Kyosseva, S. V., Chen, L., Seal, S., & McGinnis, J. F. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.08.003 · Cited by 82
Sakai, K., Tiebel, O., Ljungberg, M. C., Sullivan, M., Lee, H.-J., Terashima, T., Li, R., Kobayashi, K., Lu, H.-C., Chan, L., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.030 · Cited by 23
ADAM17 mediates ectodomain shedding of the soluble VLDL receptor fragment in the retinal epithelium
Ma, X., Takahashi, Y., Wu, W., Liang, W., Chen, J., Chakraborty, D., Li, Y., Du, Y., Benyajati, S., & Ma, J.-X. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101185 · Cited by 9
Self-citation
Metadata
- Authors
- Chen, Y., Hu, Y., Lu, K., Flannery, J. G., & Ma, J.-X.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 282
- Issue
- 47
- Pages
- 34420-34428
- ISSN
- 0021-9258
- Cited by
- 92
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review